IPO
-
-
-
-
-
-
-
Vivani Medical (VANI) to Spin Off Cortigent Neurostimulation Business
-
-
-
-
-
-
-
Vivani Medical (VANI) Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
-
-
-
-
-
-
-
Vivani Medical (VANI) Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic/Wegovy and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
-
-
-
-
-
-
-
Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the OrionĀ® Visual Cortical Prosthesis System
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

